Clinical Trial Update: Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sunitinib malate with hormonal ablation for men undergoing prostatectomy for prostate cancer is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING